Venue: Philadelphia, USA
Dates: 26 – 27 June 2017
Cellular therapies hold the potential to revolutionize health care for a variety of diseases. The aim of the conference is to assess the risks and benefits of the cell culture and cell therapy bio-manufacturing by focusing in particular on the feasibility of process automation: its impact on regulatory compliance and return on investment.
At the Cell Culture & Cell Therapy: Bioprocessing Conference scheduled to be held in Philadelphia, USA on 26 – 27 June 2017, leading experts in the industry will gather to discuss strategies, technologies and innovations in the area of bioprocessing of cell culture and cell-gene therapies.
Contact Mr Amit Shelke at email@example.com for further information.
As a reader of Biotechin.Asia you are entitled to 20% discount on registration fees. Use discount code (MM-BioTI)